International business

International business Home

Today, at the age of globalization, it is a world without boundaries. With the aim to cope with the challenges of globalization the company started its export operation in 2000, Vietnam being the first destination. Today Aristopharma is exporting its world class pharmaceutical finished products to 25 countries of 5 continents. It is the first pharmaceutical company in Bangladesh to export to a developed country like Hong Kong & 2nd company to export to Singapore.

Presently Aristopharma is exporting a wide range of pharma products of different therapeutic classes. In addition to that it is also exporting sterile ophthalmic products to many countries including Nigeria, Myanmar, and Vietnam etc. In Myanmar it is no. 1 in ophthalmic business in terms of market share.

Aristopharma has a large portfolio of 200 generics in 400 dosage forms of different therapeutic classes such as antiulcerants, antibiotics, NSAIDs, antipyretics, vitamins & minerals, laxatives, cardiovascular, antidiabetics, steroids, antispasmodics, antihistamines, antipsychotics etc. Apart from normal tablet & capsule it has many technologically advanced dosage forms like inhalers, lyophilized injections, pre-filled syringes, suppositories, insulin, & other bio-tech products. Aristopharma always thrives to introduce hi-tech & innovative dosage forms for the better treatment of the patients. Its state-of-the-art facility is planned and designed with fine tuned orientation to meet both local and international demand. Moreover, recently Aristopharma has opened its new UK MHRA standard plant at Gacha, Gazipur with dedicated facility for cephalosporin products. Construction work of dedicated Ophthalmic & Oncology plants are also running in full swing in this new campus.

The mission of Aristopharma is always guided by its philosophy -"Quality- the unit we count". Hence its efforts to improve quality never ends up. It continuously sets higher standards and feels passionate to achieve all that. WHO approved cGMP guidelines are strictly followed in every single operation of the plant to produce quality products. Moreover, each & every person of the company is working relentlessly to uphold its quality image. And this is the key reason of Aristopharma's quality medicines getting respect, recognition and practicing reference by the medical practitioners of the country and now abroad.

For its honest promise to the society and well-being of global population Aristopharma never uses any ingredient while manufacturing its products that is harmful to human or to nature. This is manifest clearly in its inhalers manufacturing facility. It has established an ultra modern facility to manufacture inhaler products, which are completely CFC free. Practically Aristopharma is the first manufacturer of only HFA inhalers for asthmatic patients in the country. Aristopharma's built-in Effluent Treatment Plant (ETP) ensures environment-friendly pharmaceutical waste management practices.

To expedite its export mission Aristopharma conducted bioequivalence studies for many of its products like Omep (Omeprazole) Capsule, Metacard MR (Trimetazidine) Tablet, Lodipin-5 (Amlodipine) Tablet, AZ (Azithromycin) Capsule & Suspension, Aropen (Meropenem) Injection etc. These bioequivalence reports have already been accepted by the regulatory bodies of several countries and thus are helping in export. Aristopharma also conducted clinical trials on its products e.g. Afix (Cefixime), Taxetil (Cefpodoxime), Metacard MR (Trimetazidine) etc. and some trials are in progress.

Aristopharma is moving aggressively to increase its market share in the operating countries as well as to explore new countries. Some African countries & countries of Middle East and Latin America are under active search.

Current destinations:

Asia :Singapore, Hong Kong, Sri Lanka, Myanmar, Maldives, Vietnam, Bhutan, Macau, Philippines, Afghanistan, Uzbekistan & Azerbaijan
East Europe : Ukraine & Georgia
North America : Jamaica
Africa : Nigeria, Somalia, Mauritius & Morocco
Oceania : Fiji, Kiribati, Tonga, Samoa, Solomon Islands & Vanuatu

Pipeline destinations:

African countries & countries of Middle East and Latin America

We export our products to the following countries:



Singapore

Hong Kong

Sri Lanka

Myanmar

Maldives

Vietnam

Bhutan

Macau

Philippines

Afghanistan

Uzbekistan

Azerbaijan

Ukraine

Georgia

Jamaica

Nigeria

Somalia

Mauritius

Morocco

Fiji

Kiribati

Tonga

Samoa

Solomon

Vanuatu

GMP Compliance Certificates


PHARMACY AND POISONS BOARD, KENYA
NATIONAL AGENCY FOR FOOD AND DRUG ADMINISTRATION AND CONTROL, NIGERIA

© 2017. Aristopharma Ltd. All rights reserved.
Site by DIGITA iNTERACTIVE

HOME | PRODUCTS | FACILITIES | GLOBAL PRESENCE | NEWS | ABOUT US | CONTACT | CAREER

Webmail
Bookmark and Share